$HDSN
HUDSON TECHNOLOGIES INC /NY

2021 Q4 Form 10-Q Financial Statement

#000110465921139215 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $37.78M $60.65M $41.47M
YoY Change 70.85% 46.25% -9.12%
Cost Of Revenue $20.76M $36.97M $32.51M
YoY Change 24.43% 13.71% -14.11%
Gross Profit $17.02M $23.68M $8.956M
YoY Change 213.44% 164.38% 15.12%
Gross Profit Margin 45.06% 39.04% 21.6%
Selling, General & Admin $6.980M $6.072M $6.162M
YoY Change 8.05% -1.46% -25.58%
% of Gross Profit 41.01% 25.64% 68.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.545M $1.544M $1.800M
YoY Change 120.71% -14.22% -2.17%
% of Gross Profit 9.08% 6.52% 20.1%
Operating Expenses $7.678M $6.770M $6.877M
YoY Change 6.94% -1.56% -23.76%
Operating Profit $9.342M $16.91M $2.079M
YoY Change -633.83% 713.28% -267.66%
Interest Expense -$2.844M -$2.843M -$2.966M
YoY Change -2.6% -4.15% -33.35%
% of Operating Profit -30.44% -16.81% -142.66%
Other Income/Expense, Net -$25.00K $1.000M
YoY Change -225.0% -88.76%
Pretax Income $6.498M $16.54M $113.0K
YoY Change -239.74% 14537.17% -96.49%
Income Tax $310.0K $670.0K $74.00K
% Of Pretax Income 4.77% 4.05% 65.49%
Net Earnings $6.188M $15.87M $39.00K
YoY Change -230.27% 40592.31% -98.54%
Net Earnings / Revenue 16.38% 26.17% 0.09%
Basic Earnings Per Share $0.36 $0.00
Diluted Earnings Per Share $130.8K $0.34 $0.00
COMMON SHARES
Basic Shares Outstanding 43.97M 43.87M 42.66M
Diluted Shares Outstanding 46.96M 43.68M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.492M $9.503M $9.200M
YoY Change 168.62% 3.29% -37.41%
Cash & Equivalents $3.492M $9.503M $9.235M
Short-Term Investments
Other Short-Term Assets $8.090M $11.00M $3.500M
YoY Change 24.46% 214.17% -25.53%
Inventory $94.14M $58.79M $40.40M
Prepaid Expenses
Receivables $14.22M $22.10M $14.70M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $119.9M $101.4M $67.90M
YoY Change 93.02% 49.37% -31.07%
LONG-TERM ASSETS
Property, Plant & Equipment $20.09M $20.04M $28.20M
YoY Change -8.29% -28.95% -9.03%
Goodwill $47.80M $47.80M
YoY Change 0.0%
Intangibles $20.36M $21.06M
YoY Change -12.06%
Long-Term Investments
YoY Change
Other Assets $710.0K $169.0K $100.0K
YoY Change 735.29% 69.0% -50.0%
Total Long-Term Assets $95.77M $95.71M $99.90M
YoY Change -3.76% -4.19% -5.49%
TOTAL ASSETS
Total Short-Term Assets $119.9M $101.4M $67.90M
Total Long-Term Assets $95.77M $95.71M $99.90M
Total Assets $215.7M $197.1M $167.8M
YoY Change 33.45% 17.48% -17.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.623M $6.696M $9.500M
YoY Change 26.62% -29.52% 17.28%
Accrued Expenses $13.99M $19.24M $21.00M
YoY Change 162.45% -8.39% -0.47%
Deferred Revenue
YoY Change
Short-Term Debt $15.00M $7.000M $0.00
YoY Change 650.0%
Long-Term Debt Due $5.248M $5.248M $6.900M
YoY Change -28.25% -23.94% -93.97%
Total Short-Term Liabilities $64.44M $50.78M $37.40M
YoY Change 70.61% 35.78% -73.97%
LONG-TERM LIABILITIES
Long-Term Debt $73.15M $74.25M $79.50M
YoY Change -6.2% -6.61%
Other Long-Term Liabilities $5.500M $3.635M $4.300M
YoY Change 41.03% -15.47% -4.44%
Total Long-Term Liabilities $73.15M $74.25M $83.80M
YoY Change -6.2% -11.4% 1762.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.44M $50.78M $37.40M
Total Long-Term Liabilities $73.15M $74.25M $83.80M
Total Liabilities $144.8M $130.2M $122.5M
YoY Change 19.62% 6.28% -17.95%
SHAREHOLDERS EQUITY
Retained Earnings -$45.82M -$52.01M
YoY Change -41.32%
Common Stock $448.0K $440.0K
YoY Change 3.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $70.94M $66.94M $45.21M
YoY Change
Total Liabilities & Shareholders Equity $215.7M $197.1M $167.8M
YoY Change 33.45% 17.48% -17.83%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $6.188M $15.87M $39.00K
YoY Change -230.27% 40592.31% -98.54%
Depreciation, Depletion And Amortization $1.545M $1.544M $1.800M
YoY Change 120.71% -14.22% -2.17%
Cash From Operating Activities -$9.252M $16.45M $17.29M
YoY Change 13.38% -4.84% -46.6%
INVESTING ACTIVITIES
Capital Expenditures -$1.257M -$247.0K -$410.0K
YoY Change 167.45% -39.76% -36.92%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.000M
YoY Change
Cash From Investing Activities -$1.257M -$247.0K $590.0K
YoY Change 167.45% -141.86% -190.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.498M -8.577M -16.50M
YoY Change 499.73% -48.02% -10.08%
NET CHANGE
Cash From Operating Activities -9.252M 16.45M 17.29M
Cash From Investing Activities -1.257M -247.0K 590.0K
Cash From Financing Activities 4.498M -8.577M -16.50M
Net Change In Cash -6.011M 7.630M 1.380M
YoY Change -23.72% 452.9% -89.69%
FREE CASH FLOW
Cash From Operating Activities -$9.252M $16.45M $17.29M
Capital Expenditures -$1.257M -$247.0K -$410.0K
Free Cash Flow -$7.995M $16.70M $17.70M
YoY Change 3.97% -5.64% -46.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
dei Entity Central Index Key
EntityCentralIndexKey
0000925528
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43347887
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43959748
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13412
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address Address Line1
EntityAddressAddressLine1
1 Blue Hill Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
P.O. Box 1541
dei Entity Address City Or Town
EntityAddressCityOrTown
Pearl River
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10965
dei City Area Code
CityAreaCode
845
dei Local Phone Number
LocalPhoneNumber
735-6000
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
HDSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43969748
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9503000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1348000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22131000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9806000
CY2021Q3 us-gaap Inventory Net
InventoryNet
58789000
CY2020Q4 us-gaap Inventory Net
InventoryNet
44460000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10996000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6528000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
101419000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
62142000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20035000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21910000
CY2021Q3 us-gaap Goodwill
Goodwill
47803000
CY2020Q4 us-gaap Goodwill
Goodwill
47803000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21055000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23150000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6652000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6559000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
169000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
85000
CY2021Q3 us-gaap Assets
Assets
197133000
CY2020Q4 us-gaap Assets
Assets
161649000
CY2021Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
6696000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
7644000
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
16298000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8080000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2940000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1394000
CY2021Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
12600000
CY2020Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
11337000
CY2021Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
7000000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2000000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
5248000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7314000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
50782000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37769000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1530000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1355000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3635000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3927000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
74248000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
77976000
CY2021Q3 us-gaap Liabilities
Liabilities
130195000
CY2020Q4 us-gaap Liabilities
Liabilities
121027000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43959748
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43347887
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
440000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
433000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118507000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118269000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52009000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78080000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
66938000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40622000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
197133000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
161649000
CY2021Q3 us-gaap Revenues
Revenues
60645000
CY2020Q3 us-gaap Revenues
Revenues
41468000
us-gaap Revenues
Revenues
154973000
us-gaap Revenues
Revenues
125495000
CY2021Q3 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
36967000
CY2020Q3 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
32512000
hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
100329000
hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
95511000
CY2021Q3 us-gaap Gross Profit
GrossProfit
23678000
CY2020Q3 us-gaap Gross Profit
GrossProfit
8956000
us-gaap Gross Profit
GrossProfit
54644000
us-gaap Gross Profit
GrossProfit
29984000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6072000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6162000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19586000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20184000
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
CY2020Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
715000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2095000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2147000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
113000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6770000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
6877000
us-gaap Operating Expenses
OperatingExpenses
21681000
us-gaap Operating Expenses
OperatingExpenses
22331000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16908000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2079000
us-gaap Operating Income Loss
OperatingIncomeLoss
32963000
us-gaap Operating Income Loss
OperatingIncomeLoss
7653000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2843000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2966000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8532000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9412000
CY2021Q3 us-gaap Other Income
OtherIncome
2475000
CY2020Q3 us-gaap Other Income
OtherIncome
1000000
us-gaap Other Income
OtherIncome
2470000
us-gaap Other Income
OtherIncome
1011000
CY2021Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-368000
CY2020Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-1966000
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-6062000
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-8401000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16540000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26901000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-748000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
670000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
830000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-288000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
15870000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
39000
us-gaap Net Income Loss
NetIncomeLoss
26071000
us-gaap Net Income Loss
NetIncomeLoss
-460000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43870825
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42656510
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43576211
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42637945
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46964522
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43680265
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46412691
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42637945
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
44945000
us-gaap Profit Loss
ProfitLoss
26071000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
66938000
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
191000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
39000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
45210000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
51197000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
77000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
346000
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
139000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
15870000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
66938000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45111000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
524000
us-gaap Profit Loss
ProfitLoss
-460000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
45210000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40622000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
81000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
346000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
509000
us-gaap Net Income Loss
NetIncomeLoss
26071000
us-gaap Net Income Loss
NetIncomeLoss
-460000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2540000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3235000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2095000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2147000
us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
1000000
hdsn Payment Protection Program Forgiveness
PaymentProtectionProgramForgiveness
-2475000
hdsn Finance Lease Right Of Use Asset Amortization Reversal
FinanceLeaseRightOfUseAssetAmortizationReversal
5000
hdsn Finance Lease Right Of Use Asset Amortization Reversal
FinanceLeaseRightOfUseAssetAmortizationReversal
14000
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-2024000
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-3622000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
724000
us-gaap Share Based Compensation
ShareBasedCompensation
509000
us-gaap Share Based Compensation
ShareBasedCompensation
559000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
841000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
843000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
175000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
104000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12348000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7366000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12305000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22486000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4771000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-873000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1039000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6635000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2600000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9503000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
351000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8649000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1664000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8024000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19850000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
665000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
996000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-665000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-264000
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
2475000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
5000000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-14000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3940000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1694000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
796000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13219000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8155000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9235000
us-gaap Interest Paid Net
InterestPaidNet
7635000
us-gaap Interest Paid Net
InterestPaidNet
8745000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
278000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
41000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances. At September 30, 2021, the Company had trade receivables of $23.8 million, and allowance for doubtful accounts of $1.7 million, resulting in net accounts receivable of $22.1 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the nine month period ended September 30, 2021 there was one customer accounting for 10% of the Company’s revenues and at September 30, 2021 there were $3.0 million of accounts receivable from this customer. For the nine month period ended September 30, 2020 there was one customer accounting for 13% of the Company’s revenues and at September 30, 2020 there were $2.0 million of accounts receivable from this customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
23800000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1700000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22100000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
29800000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16300000
CY2021Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
4900000
CY2021Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14100000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
15870000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
39000
us-gaap Net Income Loss
NetIncomeLoss
26071000
us-gaap Net Income Loss
NetIncomeLoss
-460000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43870825
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42656510
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43576211
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42637945
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46964522
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43680265
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46412691
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42637945
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28276
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7043259
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
59119
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7043259
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used including potential impact of COVID-19 uncertainties. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Several of the Company's accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
CY2021Q3 us-gaap Inventory Gross
InventoryGross
65889000
CY2020Q4 us-gaap Inventory Gross
InventoryGross
53593000
CY2021Q3 us-gaap Inventory Adjustments
InventoryAdjustments
7100000
CY2020Q4 us-gaap Inventory Adjustments
InventoryAdjustments
9133000
CY2021Q3 us-gaap Inventory Net
InventoryNet
58789000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8240000
CY2021Q3 hdsn Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
2932000
CY2020Q4 us-gaap Inventory Net
InventoryNet
44460000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52949000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52284000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32914000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30374000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20035000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21910000
us-gaap Depreciation
Depreciation
2500000
us-gaap Depreciation
Depreciation
3200000
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1454000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1415000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1412000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1027000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1512000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6728000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3635000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6728000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M21D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0822
us-gaap Operating Lease Payments
OperatingLeasePayments
2500000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Goodwill
Goodwill
47800000
CY2020Q4 us-gaap Goodwill
Goodwill
47800000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33397000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12342000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21055000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33397000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10247000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23150000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
CY2021Q3 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
3739235
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y
CY2021Q3 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Non Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonVested
1.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
463754
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
254700
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7042377
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.01
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1967562
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.91
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
254700
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.11
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5329515
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
107447
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.11
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1373905
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
463754
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.71
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4311917
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.04
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4311917
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y9M18D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.04
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10700000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
700000
CY2021Q3 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
5700
CY2020Q4 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2100000
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7000000
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2021Q3 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
0
CY2020Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
2062000
CY2021Q3 hdsn Capital Lease Obligation Current
CapitalLeaseObligationCurrent
0
CY2020Q4 hdsn Capital Lease Obligation Current
CapitalLeaseObligationCurrent
4000
CY2021Q3 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
5248000
CY2020Q4 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
5248000
CY2021Q3 us-gaap Debt Current
DebtCurrent
12248000
CY2020Q4 us-gaap Debt Current
DebtCurrent
9314000
CY2021Q3 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
75931000
CY2020Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
79867000
CY2021Q3 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
0
CY2020Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
413000
CY2021Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1683000
CY2020Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2304000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
74248000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
77976000
CY2021Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
86496000
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
87290000
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
5248000
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
5248000
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
70683000
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
81179000

Files In Submission

Name View Source Status
0001104659-21-139215-index-headers.html Edgar Link pending
0001104659-21-139215-index.html Edgar Link pending
0001104659-21-139215.txt Edgar Link pending
0001104659-21-139215-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdsn-20210930.xsd Edgar Link pending
hdsn-20210930x10q.htm Edgar Link pending
hdsn-20210930x10q_htm.xml Edgar Link completed
hdsn-20210930xex31d1.htm Edgar Link pending
hdsn-20210930xex31d2.htm Edgar Link pending
hdsn-20210930xex32d1.htm Edgar Link pending
hdsn-20210930xex32d2.htm Edgar Link pending
hdsn-20210930_cal.xml Edgar Link unprocessable
hdsn-20210930_def.xml Edgar Link unprocessable
hdsn-20210930_lab.xml Edgar Link unprocessable
hdsn-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending